JP2003342149A - Skin care preparation - Google Patents

Skin care preparation

Info

Publication number
JP2003342149A
JP2003342149A JP2002149521A JP2002149521A JP2003342149A JP 2003342149 A JP2003342149 A JP 2003342149A JP 2002149521 A JP2002149521 A JP 2002149521A JP 2002149521 A JP2002149521 A JP 2002149521A JP 2003342149 A JP2003342149 A JP 2003342149A
Authority
JP
Japan
Prior art keywords
extract
skin
preparation
mizuganpi
genus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002149521A
Other languages
Japanese (ja)
Other versions
JP4295473B2 (en
Inventor
Akira Hatani
彰 葉谷
Hayashi Maeda
速 前田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2002149521A priority Critical patent/JP4295473B2/en
Publication of JP2003342149A publication Critical patent/JP2003342149A/en
Application granted granted Critical
Publication of JP4295473B2 publication Critical patent/JP4295473B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a skin care preparation which has an antioxidizing action and an action for activating dermal fibroblasts and exhibits effects for preventing and improving ageing symptoms such as wrinkles, flabbiness, the deterioration of skin tenseness, and drabness. <P>SOLUTION: This skin care preparation contains a Pemphis plant extract having an antioxidizing action and an action for activating dermal fibroblasts effects for preventing and improving ageing symptoms such as wrinkles, flabbiness, the deterioration of skin tenseness, and drabness. <P>COPYRIGHT: (C)2004,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、シワやシミの発
生、皮膚の弾性の低下といった皮膚の老化症状の防止或
いは改善において、優れた効果を有する皮膚外用剤に関
し、さらに詳しくは、真皮線維芽細胞賦活作用と抗酸化
作用を有するミズガンピ属(Pemphis)植物抽出
物を配合した皮膚外用剤に関する。
TECHNICAL FIELD The present invention relates to an external preparation for skin having an excellent effect in preventing or ameliorating skin aging symptoms such as generation of wrinkles and spots and reduction of elasticity of skin, and more specifically, dermal fibroblasts. The present invention relates to a skin external preparation containing a plant extract of the genus Pemphis having a cell activating action and an antioxidant action.

【0002】[0002]

【従来の技術】加齢などによる真皮線維芽細胞の機能低
下は、コラーゲンやエラスチン等の真皮マトリックスの
減少や変性を引き起こし、シワや皮膚の弾性の低下とい
った老化症状の重要な要因となっている。また、紫外線
等の外来ストレスによる酸化傷害も、シワ,シミ,皮膚
の弾性の低下といった老化症状の原因となっている。こ
れまでの皮膚外用剤の分野では、係る細胞の機能低下や
酸化傷害による老化症状を防止あるいは改善するため
に、様々な細胞賦活剤や抗酸化剤の検索及び配合検討が
なされてきた。細胞賦活剤としては、例えば、ポンカン
のエッセンス(特開2001−131045)、ツリガ
ネニンジン属,クサギ及びそれらの抽出物(特開200
0−178198)、有機溶媒によるクロレラ抽出物
(特開平11−335293)等が知られており、抗酸
化剤としては、例えば、キク科へテロテカ属植物抽出物
(特開平11−180886)やカユアンギンの抽出物
(特開平10−182413)等が知られている。
2. Description of the Related Art Deterioration of dermal fibroblast function due to aging causes a decrease and degeneration of dermal matrix such as collagen and elastin, which is an important factor for aging symptoms such as wrinkles and deterioration of skin elasticity. . In addition, oxidative damage due to external stress such as ultraviolet rays is also a cause of aging symptoms such as wrinkles, stains, and reduction in skin elasticity. In the field of external preparations for skin up to now, various cell activating agents and antioxidants have been searched and studied in combination in order to prevent or ameliorate such aging symptoms due to functional deterioration of cells and oxidative damage. Examples of the cell activating agent include poncan essence (Japanese Unexamined Patent Publication No. 2001-131045), Genus Ginseng, Heron and extracts thereof (Japanese Unexamined Patent Publication No.
0-178198), a chlorella extract with an organic solvent (JP-A-11-335293), and the like are known as antioxidants, for example, a plant extract of the genus Heteroteca of the Asteraceae (JP-A-11-180886) and Cayuangin. (Japanese Patent Application Laid-Open No. 10-182413) and the like are known.

【0003】しかし、すでに報告されている生理活性物
質は、老化現象の一部の過程にのみ作用している場合が
多く、本質的な改善効果としては不十分であった。ま
た、皮膚外用剤の基剤中に配合した場合、有効な効果を
得るにはかなりの高濃度を配合しなければならず、製剤
に好ましくない色や臭いを付与してしまう場合があるな
ど、作用効果や安定性の面ですべてを満足できるものが
少ないのが現状であった。
However, the already reported physiologically active substances often act only on a part of the process of aging phenomenon, which is insufficient as an essential improving effect. Further, when blended in the base of an external preparation for skin, it is necessary to blend a considerably high concentration in order to obtain an effective effect, which may impart an undesired color or odor to the formulation. At present, there are few things that can satisfy all of the effects and stability.

【0004】[0004]

【発明が解決しようとする課題】そこで、本発明におい
ては、真皮線維芽細胞賦活作用と抗酸化作用とを有し、
皮膚の老化症状の予防や改善効果に優れた皮膚外用剤を
提供することを目的とした。
Therefore, in the present invention, it has a dermal fibroblast activating action and an antioxidant action,
It is an object of the present invention to provide an external preparation for skin which is excellent in preventing and improving skin aging symptoms.

【0005】[0005]

【課題を解決するための手段】本発明者らは、皮膚の老
化症状の予防や改善に優れた有効成分を見出すために、
種々の物質について真皮線維芽細胞賦活作用と抗酸化作
用に関する検討を行った。その結果、ミズガンピ属(
emphis)植物抽出物に優れた真皮線維芽細胞賦活
作用と抗酸化作用とを見出し、本発明を完成するに至っ
た。
[Means for Solving the Problems] In order to find an active ingredient excellent in prevention and improvement of skin aging symptoms, the present inventors have
The dermal fibroblast activation and antioxidant effects of various substances were investigated. As a result, the genus Mizuganpi ( P
The present invention has been completed by finding excellent dermal fibroblast activating action and antioxidant action in plant extracts.

【0006】[0006]

【発明の実施の形態】ミズガンピ属(Pemphis
植物は、ミソハギ科の植物でインド,マレーシア,太平
洋諸島にかけて広く分布している。ミズガンピ属(Pe
mphis)植物としては、ミズガンピ(Pemphi
acidula Forst.),マダガスカルミ
ズガンピ(Pemphis madagascarie
nsis (Bak.) H.Perr.)等が知られて
いる。
DETAILED DESCRIPTION OF THE INVENTION Mizuganpi genus (Pemphis)
The plant is a plant of the family Liliaceae, widely distributed in India, Malaysia, and the Pacific Islands. Genus Mizugumpi ( Pe
mphis ) plants include the mizugumpi ( Pemphi)
s acidula Forst. ), Madagascar Ms. Ganpi (Pemphis madagascarie
nsis (Bak.) H. Perr.) And the like are known.

【0007】これらのミズガンピ属(Pemphis
植物を使用する際は、抽出物を用いるのが一般的であ
る。抽出には、ミズガンピ属(Pemphis)植物の
幹,枝,果実,葉,花,種子,樹皮,樹液,根,芽など
のいずれの部位を用いても構わないが、簡便に利用する
には、葉や種子を用いるとよい。抽出の際は、生のまま
用いてもよいが、抽出効率を考えると、細切,乾燥,粉
砕等の処理を行った後に抽出を行うことが好ましい。抽
出は、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体
を用いた抽出方法でも行うことができる。抽出効率を上
げるため、撹拌や抽出溶媒中でホモジナイズしてもよ
い。抽出温度としては、5℃程度から抽出溶媒の沸点以
下の温度とするのが適切である。抽出時間は抽出溶媒の
種類や抽出温度によっても異なるが、1時間〜14日間
程度とするのが適切である。
These genus Pemphis
When using plants, it is common to use extracts. For the extraction, any part of the stem, branch, fruit, leaf, flower, seed, bark, sap, root, bud, etc. of the genus Pemphis may be used. Use leaves and seeds. When extracting, it may be used as it is, but in consideration of extraction efficiency, it is preferable to perform extraction after performing processes such as shredding, drying and crushing. The extraction can also be performed by immersing in an extraction solvent or by an extraction method using a supercritical fluid or subcritical fluid. In order to improve extraction efficiency, stirring or homogenization in an extraction solvent may be performed. As the extraction temperature, it is appropriate to set the temperature to about 5 ° C. to a temperature not higher than the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but it is suitable to be about 1 hour to 14 days.

【0008】抽出溶媒としては、水の他、メタノール,
エタノール,プロパノール,イソプロパノール等の低級
アルコール、1,3−ブチレングリコール,プロピレン
グリコール,ジプロピレングリコール,グリセリン等の
多価アルコール、エチルエーテル,プロピルエーテル等
のエーテル類、酢酸エチル,酢酸ブチル等のエステル
類、アセトン,エチルメチルケトン等のケトン類などの
溶媒を用いることができ、これらより1種又は2種以上
を選択して用いる。また、生理食塩水,リン酸緩衝液,
リン酸緩衝生理食塩水等を用いてもよい。さらに、水や
二酸化炭素,エチレン,プロピレン,エタノール,メタ
ノール,アンモニアなどの1種又は2種以上の超臨界流
体や亜臨界流体を用いてもよい。
As the extraction solvent, in addition to water, methanol,
Lower alcohols such as ethanol, propanol and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin, ethers such as ethyl ether and propyl ether, and esters such as ethyl acetate and butyl acetate. Solvents such as ketones such as acetone, acetone, and ethyl methyl ketone can be used, and one or more selected from these solvents are used. Also, saline, phosphate buffer,
Phosphate buffered saline may be used. Further, one or more supercritical fluids or subcritical fluids such as water, carbon dioxide, ethylene, propylene, ethanol, methanol and ammonia may be used.

【0009】ミズガンピ属(Pemphis)植物の上
記溶媒による抽出物は、そのままでも使用することがで
きるが、濃縮,乾固した物を水や極性溶媒に再度溶解し
たり、或いはこれらの生理作用を損なわない範囲で脱
色,脱臭,脱塩等の精製処理を行ったり、カラムクロマ
トグラフィー等による分画処理を行った後に用いてもよ
い。ミズガンピ属(Pemphis)植物の前記抽出物
やその処理物及び分画物は、各処理及び分画後に凍結乾
燥し、用時に溶媒に溶解して用いることもできる。ま
た、リポソーム等のベシクルやマイクロカプセル等に内
包させて用いることもできる。
The extract of the Pemphis plant with the above solvent can be used as it is, but the concentrated and dried product is redissolved in water or a polar solvent, or its physiological action is impaired. It may be used after purification treatment such as decolorization, deodorization, and desalting within a range not present, or after fractionation treatment by column chromatography or the like. The above-mentioned extract of the Pemphis plant and its treated products and fractions can be freeze-dried after each treatment and fractionation, and dissolved in a solvent before use. It can also be used by encapsulating it in vesicles such as liposomes or in microcapsules.

【0010】本発明においては、ミズガンピ属(Pem
phis)植物抽出物を皮膚外用剤に配合することによ
り、シワ、タルミ、肌のハリの低下、及びクスミ等の老
化症状の予防や改善に優れた効果を発揮する。
In the present invention, the genus Mizugumpi ( Pem
By adding a phis ) plant extract to a skin external preparation, it exerts an excellent effect in preventing and improving aging symptoms such as wrinkles, tarmi, skin firmness and dullness.

【0011】本発明における真皮線維芽細胞賦活作用と
抗酸化作用を有する皮膚外用剤は、ミズガンピ属(Pe
mphis)植物抽出物を有効成分とする。
The external preparation for skin having a dermal fibroblast activating action and an antioxidant action according to the present invention is a genus Mizugumpi ( Pe
mphis ) plant extract as an active ingredient.

【0012】本発明におけるミズガンピ属(Pemph
is)植物抽出物の配合量は、皮膚外用剤の種類や目的
等によって調整することができるが、皮膚外用剤の全量
に対して、0.0001〜10.0重量%が好ましく、
より好ましくは、0.001〜5.0重量%である。
[0012] Mizuganpi genus in the present invention (Pemph
is ) The blending amount of the plant extract can be adjusted depending on the type and purpose of the skin external preparation, but is preferably 0.0001 to 10.0% by weight based on the total amount of the skin external preparation,
More preferably, it is 0.001 to 5.0% by weight.

【0013】本発明に係る皮膚外用剤は、ローション,
乳液,ゲル,クリーム,軟膏剤,粉末,顆粒等、種々の
剤型で提供することができる。
The external preparation for skin according to the present invention is a lotion,
It can be provided in various dosage forms such as emulsion, gel, cream, ointment, powder and granules.

【0014】なお、本発明に係る皮膚外用剤には、ミズ
ガンピ属(Pemphis)植物抽出物の他に、通常医
薬品,医薬部外品,皮膚化粧料,毛髪用化粧料及び洗浄
料に配合される、油性成分,保湿剤,粉体,色素,乳化
剤,可溶化剤,洗浄剤,紫外線吸収剤,増粘剤,薬剤,
香料,樹脂,防菌防黴剤,アルコール類等を適宜配合す
ることができる。また、本発明の効果を損なわない範囲
において、他の細胞賦活剤,抗酸化剤,植物抽出物との
併用も可能である。
The external preparation for skin according to the present invention is compounded in ordinary pharmaceutical products, quasi-drugs, skin cosmetics, hair cosmetics and cleansers in addition to the plant extract of the genus Pemphis. , Oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, detergents, UV absorbers, thickeners, drugs,
Fragrances, resins, antibacterial and antifungal agents, alcohols and the like can be appropriately mixed. Further, it may be used in combination with other cell activators, antioxidants and plant extracts as long as the effects of the present invention are not impaired.

【0015】[0015]

【実施例】さらに実施例により、本発明の特徴について
詳細に説明する。まず、本発明のミズガンピ属(Pem
phis)植物抽出物の調製方法について示す。
EXAMPLES The features of the present invention will be described in more detail with reference to examples. First, the genus Mizugumpi of the present invention ( Pem
phis ) A method for preparing a plant extract will be described.

【0016】[調製方法1]ミズガンピ属(Pemph
is)植物の乾燥粉砕物1kgに50重量%エタノール
水溶液を10リットル加え、室温で7日間浸漬した。抽
出液をろ過して回収し、溶媒を除去した後、ミズガンピ
属(Pemphis)植物抽出物を得た。
[Preparation Method 1] Genus Mizugumpi ( Pemph)
is ) 10 liters of a 50% by weight aqueous ethanol solution was added to 1 kg of the dried and pulverized plant material, and the mixture was immersed at room temperature for 7 days. The extract was filtered and collected, and the solvent was removed to obtain a Pemphis plant extract.

【0017】[調製方法2]ミズガンピ属(Pemph
is)植物の乾燥粉砕物1kgに水を9リットル加え、
90℃にて6時間還流して抽出した。抽出液をろ過して
回収し、溶媒を除去した後、ミズガンピ属(Pemph
is)植物抽出物を得た。
[Preparation Method 2] Genus Mizugumpi ( Pemph)
is ) Add 9 liters of water to 1 kg of dried and ground plant,
Reflux for 6 hours at 90 ° C. for extraction. The extract was recovered by filtration, after removal of the solvent, Mizuganpi genus (Pemph
is ) A plant extract was obtained.

【0018】[調製方法3]ミズガンピ属(Pemph
is)植物の乾燥粉砕物1kgにメタノールを9リット
ル加え、室温で7日間浸漬した。抽出液をろ過して回収
し、溶媒を除去した後、ミズガンピ属(Pemphi
)植物抽出物を得た。
[Preparation Method 3] Genus Mizugumpi ( Pemph)
is ) To 1 kg of the dried and pulverized plant material, 9 liters of methanol was added and immersed at room temperature for 7 days. The extract was recovered by filtration, after removal of the solvent, Mizuganpi genus (Pemphi
s ) A plant extract was obtained.

【0019】[調製方法4]超臨界抽出装置にミズガン
ピ属(Pemphis)植物を投入し、40℃において
15MPaの大気圧下で二酸化炭素の超臨界流体を用い
て抽出した。抽出物を回収し、ミズガンピ属(Pemp
his)植物抽出物を得た。
[Preparation Method 4] Plants of the genus Pemphis were put into a supercritical extraction apparatus and extracted with a supercritical fluid of carbon dioxide at 40 ° C. under an atmospheric pressure of 15 MPa. The extract was collected, and the genus Mizugumpi ( Pemp
his ) plant extract was obtained.

【0020】次に、ミズガンピ属(Pemphis)植
物抽出物の真皮線維芽細胞の賦活作用を示す。
Next, the activating effect on the dermal fibroblasts of the Pemphis plant extract will be shown.

【0021】評価は、以下の手順で行った。正常ヒト真
皮線維芽細胞を1ウェル当たり2.0×10個となる
ように96穴マイクロプレートに播種した。播種培地に
は、ダルベッコ改変イーグル培地(DMEM)に1%の
ウシ胎児血清を添加したものを用いた。24時間培養
後、ミズガンピ属(Pemphis)植物抽出物を添加
した試験培地に交換し、さらに48時間培養した。次い
で3−(4,5−ジメチル−2−チアゾリル)−2,5−ジ
フェニルテトラゾリウムブロミド(MTT)を400μ
g/mL含有する培地に交換して2時間培養し、テトラ
ゾリウム環の開環により生じるフォルマザンを2−プロ
パノールにて抽出し、マイクロプレートリーダーにて5
50nmの吸光度を測定した。同時に濁度として650
nmにおける吸光度を測定し、両測定値の差により細胞
賦活作用を評価した。ミズガンピの葉と枝の混合部位か
ら調製方法1によって得られた抽出物の評価結果を、抽
出物が無添加の場合の細胞賦活作用を100とした相対
値にて表1に示す。
The evaluation was carried out by the following procedure. Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) supplemented with 1% fetal bovine serum was used. After culturing for 24 hours, the culture medium was replaced with a test medium supplemented with a Pemphis plant extract, and further cultivated for 48 hours. Next, add 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) to 400 μm.
The medium was replaced with a medium containing g / mL, and the cells were cultured for 2 hours. The formazan generated by the ring opening of the tetrazolium ring was extracted with 2-propanol, and the cells were mixed with a microplate reader 5
Absorbance at 50 nm was measured. At the same time turbidity is 650
The absorbance at nm was measured, and the cell activation effect was evaluated by the difference between both measured values. Table 1 shows the evaluation results of the extract obtained by the preparation method 1 from the mixed part of leaves and branches of Mizuganpi, in which the cell activation action when the extract was not added was 100.

【0022】[0022]

【表1】 [Table 1]

【0023】表1より、ミズガンピ抽出物では、ミズガ
ンピ抽出物を0.25〜1.0mg/mL添加した場合
に、無添加の場合と比較して、危険率1%未満で有意な
線維芽細胞の賦活作用が認められた。このことから、ミ
ズガンピ属(Pemphis)植物抽出物は、優れた線
維芽細胞賦活作用を有することが明らかとなった。
From Table 1, it can be seen that in the extract of Mizuganpi, significant addition of 0.25 to 1.0 mg / mL of Mizugunpi extract resulted in significant fibroblasts with a risk rate of less than 1% as compared with the case of no addition. The activating effect of was confirmed. From this, it was revealed that the plant extract of the genus Pemphis has an excellent fibroblast activating effect.

【0024】次に、ミズガンピ属(Pemphis)植
物抽出物の抗酸化作用について示す。
Next, the antioxidant effect of the extract of Pemphis plant will be shown.

【0025】評価は、以下の手順で行った。50重量%
エタノール水溶液にて0.1mg/mLの濃度に希釈し
たミズガンピ抽出物溶液を試料として96穴マイクロプ
レートに100μL添加した。次に、0.2mMの濃度
になるようにエタノールにて調製した1,1−ジフェニ
ル−2−ピクリルヒドラジル(DPPH)溶液を96穴
マイクロプレートに100μL添加した。攪拌しながら
暗所に放置し、10分後と17時間後に516nmの吸
光度を測定した。試料を添加しなかった場合の吸光度を
(A)、試料を添加した場合の吸光度を(B)としたと
き、式(1)の値をラジカル消去率とした。 式(1) {1−(B)/(A)}×100(%) ミズガンピの葉と枝の混合部位より調製方法1によって
得られた抽出物の実験結果を表2に示す。
The evaluation was carried out by the following procedure. 50% by weight
100 µL of a Mizuganpi extract solution diluted to a concentration of 0.1 mg / mL with an aqueous ethanol solution was added to a 96-well microplate as a sample. Next, 100 μL of a 1,1-diphenyl-2-picrylhydrazyl (DPPH) solution prepared with ethanol to a concentration of 0.2 mM was added to a 96-well microplate. The mixture was left in the dark with stirring, and the absorbance at 516 nm was measured after 10 minutes and 17 hours. When the absorbance when the sample was not added was (A) and the absorbance when the sample was added was (B), the value of the formula (1) was defined as the radical scavenging rate. Formula (1) {1- (B) / (A)} × 100 (%) Table 2 shows the experimental results of the extract obtained by the preparation method 1 from the mixed part of leaves and branches of Mizuganpi.

【0026】[0026]

【表2】 [Table 2]

【0027】表2より明らかなように、ミズガンピ属
Pemphis)植物抽出物は、優れた抗酸化作用を
有することが分かった。
As is clear from Table 2, it was found that the plant extract of the genus Pemphis has an excellent antioxidant effect.

【0028】続いて、本発明に係るミズガンピ属(Pe
mphis)植物抽出物を配合した実施例の処方を示す
が、実施例7〜19における処方に配合したミズガンピ
抽出物及びマダガスカルミズガンピ抽出物とは、葉と枝
の混合部位からの抽出物である。
Then, the genus Mizugumpi ( Pe according to the present invention)
mphis ) The formulation of the example which mix | blended the plant extract is shown, but the Mizuganpi extract and Madagascar Mizuganpi extract which were mix | blended with the formulation in Examples 7-19 are extracts from the mixing part of a leaf and a branch. .

【0029】 [実施例1〜6]乳液 (1)スクワラン 10.0(重量%) (2)メチルフェニルポリシロキサン 4.0 (3)水素添加パーム核油 0.5 (4)水素添加大豆リン脂質 0.1 (5)モノステアリン酸ポリオキシエチレン ソルビタン(20E.O.) 1.3 (6)モノステアリン酸ソルビタン 1.0 (7)グリセリン 10.0 (8)パラオキシ安息香酸メチル 0.1 (9)カルボキシビニルポリマー 0.15 (10)精製水 50.85 (11)アルギニン(1重量%水溶液) 20.0 (12)表3記載のオヒルギ属植物抽出物 2.0 製法:(1)〜(6)の油相成分を80℃にて加熱溶解
する。一方(7)〜(10)の水相成分を80℃にて加熱
溶解する。これに前記油相成分を攪拌しながら加え、ホ
モジナイザーにより均一に乳化する。乳化終了後、冷却
を開始し、(11)と(12)を順次加え、均一に混合す
る。
Examples 1 to 6 Emulsion (1) Squalane 10.0 (% by weight) (2) Methylphenylpolysiloxane 4.0 (3) Hydrogenated palm kernel oil 0.5 (4) Hydrogenated soybean phosphorus Lipid 0.1 (5) Polyoxyethylene sorbitan monostearate (20 EO) 1.3 (6) Sorbitan monostearate 1.0 (7) Glycerin 10.0 (8) Methyl paraoxybenzoate 0.1 (9) Carboxyvinyl polymer 0.15 (10) Purified water 50.85 (11) Arginine (1% by weight aqueous solution) 20.0 (12) Orchugi plant extract 2.0 shown in Table 3 Production method: (1) The oil phase components (6) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C. The oil phase component is added to this with stirring, and the mixture is uniformly emulsified with a homogenizer. After the emulsification is completed, cooling is started, and (11) and (12) are added in order and mixed uniformly.

【0030】[0030]

【表3】 [Table 3]

【0031】 [実施例7]化粧水 (1)エタノール 15.0(重量%) (2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3 (3)香料 0.1 (4)精製水 81.36 (5)クエン酸 0.02 (6)クエン酸ナトリウム 0.1 (7)グリセリン 3.0 (8)ヒドロキシエチルセルロース 0.1 (9)ミズガンピ抽出物[調製方法3] 0.02 製法:(1)に(2)及び(3)を溶解する。溶解後、
(4)〜(8)を順次添加した後、十分に攪拌し、
(9)を加え、均一に混合する。
[Example 7] Lotion (1) Ethanol 15.0 (wt%) (2) Polyoxyethylene (40EO) hydrogenated castor oil 0.3 (3) Perfume 0.1 (4) Purification Water 81.36 (5) Citric acid 0.02 (6) Sodium citrate 0.1 (7) Glycerin 3.0 (8) Hydroxyethyl cellulose 0.1 (9) Mizuganpi extract [Preparation method 3] 0.02 Manufacturing method: (2) and (3) are dissolved in (1). After dissolution
After sequentially adding (4) to (8), thoroughly stir,
Add (9) and mix evenly.

【0032】 [実施例8]クリーム (1)スクワラン 10.0(重量%) (2)ステアリン酸 2.0 (3)水素添加パーム核油 0.5 (4)水素添加大豆リン脂質 0.1 (5)セタノール 3.6 (6)親油型モノステアリン酸グリセリン 2.0 (7)グリセリン 10.0 (8)パラオキシ安息香酸メチル 0.1 (9)アルギニン(20重量%水溶液) 15.0 (10)精製水 40.7 (11)カルボキシビニルポリマー(1重量%水溶液) 15.0 (12)ミズガンピ抽出物[調製方法1] 1.0 製法:(1)〜(6)の油相成分を80℃にて加熱溶解
する。一方(7)〜(10)の水相成分を80℃にて加熱
溶解する。これに前記油相成分を攪拌しながら加え、ホ
モジナイザーにより均一に乳化する。乳化終了後、(1
1)を加え、冷却を開始し、40℃にて(12)を加え、
均一に混合する。
[Example 8] Cream (1) Squalane 10.0 (wt%) (2) Stearic acid 2.0 (3) Hydrogenated palm kernel oil 0.5 (4) Hydrogenated soybean phospholipid 0.1 (5) Cetanol 3.6 (6) Lipophilic type glyceryl monostearate 2.0 (7) Glycerin 10.0 (8) Methyl paraoxybenzoate 0.1 (9) Arginine (20% by weight aqueous solution) 15.0 (10) Purified water 40.7 (11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0 (12) Mizuganpi extract [Preparation method 1] 1.0 Production method: Oil phase components of (1) to (6) Is dissolved by heating at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C. The oil phase component is added to this with stirring, and the mixture is uniformly emulsified with a homogenizer. After completion of emulsification, (1
Add 1), start cooling, add (12) at 40 ° C,
Mix evenly.

【0033】 [実施例9]美容液 (1)精製水 32.35(重量%) (2)グリセリン 10.0 (3)ショ糖脂肪酸エステル 1.3 (4)カルボキシビニルポリマー(1重量%水溶液) 17.5 (5)アルギン酸ナトリウム(1重量%水溶液) 15.0 (6)モノラウリン酸ポリグリセリル 1.0 (7)マカデミアナッツ油脂肪酸フィトステリル 3.0 (8)N-ラウロイル-L-グルタミン酸 ジ(フィトステリル−2−オクチルドデシル) 2.0 (9)硬化パーム油 2.0 (10)スクワラン(オリーブ由来) 1.0 (11)ベヘニルアルコール 0.75 (12)ミツロウ 1.0 (13)ホホバ油 1.0 (14)1,3−ブチレングリコール 10.0 (15)L−アルギニン(10重量%水溶液) 2.0 (16)ミズガンピ抽出物[調製方法3] 0.1 製法:(1)〜(6)の水相成分を混合し、75℃にて
加熱溶解する。一方、(7)〜(14)の油相成分を混合
し、75℃にて加熱溶解する。次いで、上記水相成分に
油相成分を添加して予備乳化を行った後、ホモミキサー
にて均一に乳化する。乳化終了後に冷却を開始し、50
℃にて(15)を加える。さらに40℃まで冷却し、(1
6)を加え、均一に混合する。
[Example 9] Beauty liquid (1) Purified water 32.35 (wt%) (2) Glycerin 10.0 (3) Sucrose fatty acid ester 1.3 (4) Carboxyvinyl polymer (1 wt% aqueous solution) ) 17.5 (5) Sodium alginate (1% by weight aqueous solution) 15.0 (6) Polyglyceryl monolaurate 1.0 (7) Macadamia nut oil fatty acid phytosteryl 3.0 (8) N-lauroyl-L-glutamate di (phytosteryl) -2-octyldodecyl) 2.0 (9) hydrogenated palm oil 2.0 (10) squalane (derived from olive) 1.0 (11) behenyl alcohol 0.75 (12) beeswax 1.0 (13) jojoba oil 1. 0 (14) 1,3-butylene glycol 10.0 (15) L-arginine (10% by weight aqueous solution) 2.0 (16) Mizuganpi extract [Preparation method 3] 0 Process 1: (1) mixing the aqueous phase component to (6), dissolved by heating at 75 ° C.. On the other hand, the oil phase components (7) to (14) are mixed and heated and dissolved at 75 ° C. Next, the oil phase component is added to the above water phase component to carry out preliminary emulsification, and then uniformly emulsified with a homomixer. Start cooling after the emulsification is completed, and
Add (15) at ℃. Further cool to 40 ℃, (1
Add 6) and mix evenly.

【0034】 [実施例10]水性ジェル (1)カルボキシビニルポリマー 0.5(重量%) (2)精製水 86.1 (3)水酸化ナトリウム(10重量%水溶液) 0.5 (4)エタノール 10.0 (5)パラオキシ安息香酸メチル 0.1 (6)香料 0.1 (7)ミズガンピ抽出物[調製方法4] 0.2 (8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1 (9)グリセリン 2.0 (10)ミズガンピ抽出物[調製方法3] 0.2 (11)マダガスカルミズガンピ抽出物[調製方法1] 0.2 製法:(1)を(2)に加え、均一に攪拌した後、
(3)を加える。均一に攪拌した後,(4)に予め溶解
した(5)を加える。均一に攪拌した後、予め混合して
おいた(6)〜(8)を加える。均一に攪拌した後、
(9)〜(11)を順次加え、均一に混合する。
Example 10 Aqueous Gel (1) Carboxyvinyl Polymer 0.5 (wt%) (2) Purified Water 86.1 (3) Sodium Hydroxide (10 wt% Aqueous Solution) 0.5 (4) Ethanol 10.0 (5) Methyl paraoxybenzoate 0.1 (6) Perfume 0.1 (7) Mizuganpi extract [Preparation method 4] 0.2 (8) Polyoxyethylene (60 EO) hydrogenated castor oil 0 .1 (9) Glycerin 2.0 (10) Mizuganpi Extract [Preparation Method 3] 0.2 (11) Madagascar Mizugunpi Extract [Preparation Method 1] 0.2 Preparation Method: (1) was added to (2) , After stirring evenly,
Add (3). After stirring uniformly, (5) dissolved in advance in (4) is added. After uniformly stirring, (6) to (8) that have been mixed in advance are added. After stirring evenly,
(9) to (11) are sequentially added and mixed uniformly.

【0035】 [実施例11]クレンジング料 (1)スクワラン 81.95 (2)イソステアリン酸ポリオキシエチレングリセリル 15.0 (3)精製水 3.0 (4)ミズガンピ抽出物[調製方法4] 0.02 (5)マダガスカルミズガンピ抽出物[調製方法4] 0.03 製法:(1)と(2)を均一に溶解する。これに、
(3)〜(5)を順次加え、均一に混合する。
[Example 11] Cleansing agent (1) Squalane 81.95 (2) Polyoxyethylene glyceryl isostearate 15.0 (3) Purified water 3.0 (4) Mizuganpi extract [Preparation method 4] 02 (5) Madagascar mizugumpi extract [Preparation method 4] 0.03 Production method: (1) and (2) are uniformly dissolved. to this,
(3) to (5) are sequentially added and mixed uniformly.

【0036】 [実施例12]洗顔フォーム (1)ステアリン酸 16.0(重量%) (2)ミリスチン酸 16.0 (3)親油型モノステアリン酸グリセリン 2.0 (4)グリセリン 20.0 (5)水酸化ナトリウム 7.5 (6)ヤシ油脂肪酸アミドプロピルベタイン 1.0 (7)精製水 36.5 (8)ミズガンピ抽出物[調製方法3] 0.5 (9)マダガスカルミズガンピ抽出物[調製方法2] 0.5 製法:(1)〜(4)の油相成分を80℃にて加熱溶解
する。一方(5)〜(7)の水相成分を80℃にて加熱
溶解し、油相成分と均一に混合撹拌する。冷却を開始
し、40℃にて(8)と(9)を加え、均一に混合す
る。
[Example 12] Facial cleansing foam (1) Stearic acid 16.0 (% by weight) (2) Myristic acid 16.0 (3) Lipophilic glyceryl monostearate 2.0 (4) Glycerin 20.0 (5) Sodium hydroxide 7.5 (6) Coconut oil fatty acid amide propyl betaine 1.0 (7) Purified water 36.5 (8) Mizuganpi extract [Preparation method 3] 0.5 (9) Madagascar Mizuganpi extract [Preparation method 2] 0.5 Manufacturing method: The oil phase components of (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and uniformly mixed with the oil phase component and stirred. Start cooling, add (8) and (9) at 40 ° C., and mix uniformly.

【0037】 [実施例13]メイクアップベースクリーム (1)スクワラン 10.0(重量%) (2)セタノール 2.0 (3)グリセリントリ−2−エチルヘキサン酸エステル 2.5 (4)親油型モノステアリン酸グリセリル 1.0 (5)プロピレングリコール 11.0 (6)ショ糖脂肪酸エステル 1.3 (7)精製水 70.4 (8)酸化チタン 1.0 (9)ベンガラ 0.1 (10)黄酸化鉄 0.4 (11)香料 0.1 (12)ミズガンピ抽出物[調製方法2] 0.1 (13)マダガスカルミズガンピ抽出物[調製方法1] 0.1 製法:(1)〜(4)の油相成分を混合し、75℃にて
加熱溶解後する。一方、(5)〜(7)の水相成分を混
合し、75℃にて加熱溶解し、これに(8)〜(10)の
顔料を加え、ホモミキサーにて均一に分散させる。この
水相成分に前記油相成分を加え、ホモミキサーにて乳化
する。乳化終了後に冷却を開始し、40℃にて(11)〜
(13)の成分を加え、均一に混合する。
Example 13 Makeup Base Cream (1) Squalane 10.0 (wt%) (2) Cetanol 2.0 (3) Glycerin Tri-2-ethylhexanoate 2.5 (4) Lipophilic Glyceryl monostearate 1.0 (5) Propylene glycol 11.0 (6) Sucrose fatty acid ester 1.3 (7) Purified water 70.4 (8) Titanium oxide 1.0 (9) Red iron oxide 0.1 ( 10) Yellow iron oxide 0.4 (11) Perfume 0.1 (12) Mizuganpi extract [Preparation method 2] 0.1 (13) Madagascar Mizugunpi extract [Preparation method 1] 0.1 Manufacturing method: (1) The oil phase components (4) to (4) are mixed and heated to dissolve at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed, heated and dissolved at 75 ° C., the pigments (8) to (10) are added thereto, and the components are uniformly dispersed by a homomixer. The oil phase component is added to the aqueous phase component and emulsified with a homomixer. After the emulsification is completed, cooling is started, and at 40 ° C (11) ~
Add the component (13) and mix evenly.

【0038】 [実施例14]乳液状ファンデーション (1)メチルポリシロキサン 2.0(重量%) (2)スクワラン 5.0 (3)ミリスチン酸オクチルドデシル 5.0 (4)セタノール 1.0 (5)ポリオキシエチレン(20E.O.) ソルビタンモノステアリン酸エステル 1.3 (6)モノステアリン酸ソルビタン 0.7 (7)1,3−ブチレングリコール 8.0 (8)キサンタンガム 0.1 (9)パラオキシ安息香酸メチル 0.1 (10)精製水 58.52 (11)酸化チタン 9.0 (12)タルク 7.4 (13)ベンガラ 0.5 (14)黄酸化鉄 1.1 (15)黒酸化鉄 0.1 (16)香料 0.1 (17)ミズガンピ抽出物[調製方法4] 0.04 (18)マダガスカルミズガンピ抽出物[調製方法3] 0.04 製法:(1)〜(6)の油相成分を混合し、75℃にて
加熱溶解する。一方、(7)〜(10)の水相成分を混合
し、75℃にて加熱溶解し、これに(11)〜(15)の顔
料を加え、ホモミキサーにて均一に分散する。油相成分
を加え、乳化を行う。乳化終了後に冷却を開始し、40
℃にて(16)〜(18)の成分を順次加え、均一に混合す
る。
Example 14 Emulsion Foundation (1) Methylpolysiloxane 2.0 (wt%) (2) Squalane 5.0 (3) Octyldodecyl myristate 5.0 (4) Cetanol 1.0 (5 ) Polyoxyethylene (20EO) sorbitan monostearate 1.3 (6) sorbitan monostearate 0.7 (7) 1,3-butylene glycol 8.0 (8) xanthan gum 0.1 (9) Methyl paraoxybenzoate 0.1 (10) Purified water 58.52 (11) Titanium oxide 9.0 (12) Talc 7.4 (13) Red iron oxide 0.5 (14) Yellow iron oxide 1.1 (15) Black Iron oxide 0.1 (16) Perfume 0.1 (17) Mizuganpi extract [Preparation method 4] 0.04 (18) Madagascar Mizuganpi extract [Preparation method 3] 0.04 Production method: (1) to (6) )of The phase components were mixed, heated and dissolved at 75 ° C.. On the other hand, the aqueous phase components (7) to (10) are mixed, heated and dissolved at 75 ° C., the pigments (11) to (15) are added thereto, and the components are uniformly dispersed with a homomixer. Add the oil phase component and emulsify. Cooling is started after the emulsification is completed, and 40
The components (16) to (18) are sequentially added at ℃ and mixed uniformly.

【0039】 [実施例15]油中水型エモリエントクリーム (1)流動パラフィン 30.0(重量%) (2)マイクロクリスタリンワックス 2.0 (3)ワセリン 5.0 (4)ジグリセリンオレイン酸エステル 5.0 (5)塩化ナトリウム 1.3 (6)塩化カリウム 0.1 (7)プロピレングリコール 3.0 (8)1,3−ブチレングリコール 5.0 (9)パラオキシ安息香酸メチル 0.1 (10)ミズガンピ抽出物[調製方法1] 0.5 (11)精製水 45.9 (12)香料 0.1 (13)マダガスカルミズガンピ抽出物[調製方法4] 2.0 製法:(5)と(6)を(11)の一部に溶解して50℃
とし、50℃に加熱した(4)に撹拌しながら徐々に加
える。これを混合した後、70℃にて加熱溶解した
(1)〜(3)に均一に分散する。これに(7)〜(1
0)を(11)の残部に70℃にて加熱溶解したものを撹
拌しながら加え、ホモミキサーにて乳化する。乳化終了
後に冷却を開始し、40℃にて(12)と(13)を加え、
均一に混合する。
[Example 15] Water-in-oil type emollient cream (1) Liquid paraffin 30.0 (% by weight) (2) Microcrystalline wax 2.0 (3) Vaseline 5.0 (4) Diglycerin oleic acid ester 5.0 (5) Sodium chloride 1.3 (6) Potassium chloride 0.1 (7) Propylene glycol 3.0 (8) 1,3-Butylene glycol 5.0 (9) Methyl paraoxybenzoate 0.1 ( 10) Mizuganpi extract [Preparation method 1] 0.5 (11) Purified water 45.9 (12) Perfume 0.1 (13) Madagascar Mizugunpi extract [Preparation method 4] 2.0 Manufacturing method: (5) Dissolve (6) in a part of (11), 50 ℃
And heated gradually to (4) heated to 50 ° C. with stirring. After mixing this, it melt | dissolves by heating at 70 degreeC and it disperses uniformly in (1)-(3). To this (7) ~ (1
What was heated and dissolved at 70 ° C. was added to the rest of (11) with stirring, and the mixture was emulsified with a homomixer. Start cooling after the emulsification, add (12) and (13) at 40 ° C,
Mix evenly.

【0040】 [実施例16]ヘアートニック (1)エタノール 50.0(重量%) (2)精製水 49.898 (3)ミズガンピ抽出物[調製方法3] 0.001 (4)マダガスカルミズガンピ抽出物[調製方法4] 0.001 (5)香料 0.1 製法:(1)〜(5)の成分を混合,均一化する。[0040]   [Example 16] Heart nick (1) Ethanol 50.0 (wt%) (2) Purified water 49.898 (3) Mizuganpi Extract [Preparation Method 3] 0.001 (4) Madagascar mizugumpi extract [Preparation method 4] 0.001 (5) Perfume 0.1 Manufacturing method: Components (1) to (5) are mixed and homogenized.

【0041】 [実施例17]パック (1)精製水 68.9(重量%) (2)ポリビニルアルコール 12.0 (3)エタノール 10.0 (4)グリセリン 5.0 (5)ポリエチレングリコール(平均分子量1000) 2.0 (6)ミズガンピ抽出物[調製方法1] 1.0 (7)マダガスカルミズガンピ抽出物[調製方法2] 1.0 (8)香料 0.1 製法:(2)と(3)を混合し、80℃に加温した後、
80℃に加温した(1)に溶解する。均一に溶解した
後、(4)〜(5)を加え、攪拌しながら冷却を開始す
る。40℃まで冷却し、(6)〜(8)を加え、均一に
混合する。
Example 17 Pack (1) Purified water 68.9 (% by weight) (2) Polyvinyl alcohol 12.0 (3) Ethanol 10.0 (4) Glycerin 5.0 (5) Polyethylene glycol (average) Molecular weight 1000) 2.0 (6) Mizugumpi extract [Preparation method 1] 1.0 (7) Madagascar Mizugumpi extract [Preparation method 2] 1.0 (8) Perfume 0.1 Manufacturing method: (2) and ( After mixing 3) and heating to 80 ° C,
It is dissolved in (1) heated to 80 ° C. After uniformly dissolving, (4) to (5) are added, and cooling is started while stirring. Cool to 40 ° C., add (6) to (8), and mix uniformly.

【0042】 [実施例18]ヘアーワックス (1)ステアリン酸 3.0(重量%) (2)マイクロクリスタリンワックス 2.0 (3)セチルアルコール 3.0 (4)高重合メチルポリシロキサン 2.0 (5)メチルポリシロキサン 5.0 (6)ポリ(オキシエチレン・オキシプロピレン) メチルポリシロキサン共重合体 1.0 (7)パラオキシ安息香酸メチル 0.1 (8)1,3−ブチレングリコール 7.5 (9)アルギニン 0.7 (10)精製水 71.6 (11)ミズガンピ抽出物[調製方法1] 2.0 (12)マダガスカルミズガンピ抽出物[調製方法1] 2.0 (13)香料 0.1 製法:(1)〜(6)の油相成分を混合し、75℃にて
加熱溶解後する。一方、(7)〜(10)の水相成分を7
5℃にて加熱溶解し、前記油相成分を加え、ホモミキサ
ーにて乳化する。乳化終了後に冷却を開始し、40℃に
て(11)〜(13)の成分を加え、均一に混合する。
[Example 18] Hair wax (1) Stearic acid 3.0 (wt%) (2) Microcrystalline wax 2.0 (3) Cetyl alcohol 3.0 (4) Highly polymerized methylpolysiloxane 2.0 (5) Methyl polysiloxane 5.0 (6) Poly (oxyethylene / oxypropylene) methyl polysiloxane copolymer 1.0 (7) Methyl paraoxybenzoate 0.1 (8) 1,3-butylene glycol 7. 5 (9) Arginine 0.7 (10) Purified water 71.6 (11) Mizuganpi Extract [Preparation Method 1] 2.0 (12) Madagascar Mizugunpi Extract [Preparation Method 1] 2.0 (13) Fragrance 0.1 Manufacturing method: The oil phase components of (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the water phase components of (7) to (10) are
It is heated and dissolved at 5 ° C., the above oil phase component is added, and the mixture is emulsified with a homomixer. After completion of the emulsification, cooling is started, and the components (11) to (13) are added at 40 ° C. and mixed uniformly.

【0043】 [実施例19]入浴剤 (1)香料 0.3(重量%) (2)ミズガンピ抽出物[調製方法1] 0.5 (3)マダガスカルミズガンピ抽出物[調製方法3] 0.5 (4)炭酸水素ナトリウム 50.0 (5)硫酸ナトリウム 48.7 製法:(1)〜(5)を均一に混合する。[0043]   [Example 19] Bath salt (1) Fragrance 0.3 (wt%) (2) Mizuganpi Extract [Preparation Method 1] 0.5 (3) Madagascar mizugumpi extract [Preparation method 3] 0.5 (4) Sodium hydrogen carbonate 50.0 (5) Sodium sulfate 48.7 Manufacturing method: (1) to (5) are uniformly mixed.

【0044】本発明の実施例1〜10について使用試験
を行い、シワ,タルミ,肌のハリ,及びクスミの改善効
果を評価した。その際、実施例1において、配合したミ
ズガンピ抽出物を精製水に代替し、比較例1として同時
に使用試験を行った。
A use test was conducted on Examples 1 to 10 of the present invention to evaluate the effect of improving wrinkles, tarmi, firmness of skin, and dullness. At that time, in Example 1, the blended Mizugumpi extract was replaced with purified water, and a use test was simultaneously performed as Comparative Example 1.

【0045】各試料について、シワ,タルミ,肌のハリ
の低下,及びクスミといった老化症状が顕著に認められ
る50〜60才代の男女パネラー各20名にブラインド
にて1カ月間使用させ、使用前後の皮膚状態の変化を観
察して評価した。皮膚の老化症状の指標として、シワ,
タルミ,肌のハリ,及びクスミについて、「改善」,
「やや改善」,「変化なし」の三段階で評価し、表4に
各評価を得たパネラー数にて示した。
For each sample, 20 male and female panelists in their 50's to 60's, in which aging symptoms such as wrinkles, tarmi, reduction of skin firmness, and dullness were noticeably observed, were used blindly for 1 month before and after use. The change in the skin condition was observed and evaluated. As an index of skin aging symptoms, wrinkles,
About Talmi, skin firmness, and dullness, "improvement",
The evaluation was made in three stages of "slightly improved" and "no change", and Table 4 shows the number of panelists who obtained each evaluation.

【0046】[0046]

【表4】 [Table 4]

【0047】表4より、シワ,タルミ,肌のハリ,及び
クスミについて、ミズガンピ属(Pemphis)植物
抽出物を含有しない比較例使用群においては、半数以上
のパネラーに改善が認められなかったが、ミズガンピ属
Pemphis)植物抽出物を配合した実施例使用群
においては、6割以上のパネラーに明確な改善が認めら
れた。
From Table 4, it was found that wrinkles, tarmi, skin firmness, and dullness were not observed in more than half of the panelists in the group of Comparative Example using no Pemphis plant extract. In the group used in the example in which the extract of the genus Pemphis was mixed, a clear improvement was observed in 60% or more of the panelists.

【0048】以上のように、本発明の実施例において
は、従来の比較例よりも、シワ,タルミ,肌のハリ,及
びクスミといった皮膚の老化症状の改善に優れた効果を
有していた。
As described above, the examples of the present invention were more effective than the conventional comparative examples in improving skin aging symptoms such as wrinkles, tarmi, skin firmness, and dullness.

【0049】[0049]

【発明の効果】以上詳述したように、本発明により、線
維芽細胞賦活作用と抗酸化作用とを有し、シワ,タル
ミ,肌のハリの低下,及びクスミ等の老化症状の予防や
改善に優れた効果を発揮する皮膚外用剤を得ることが出
来た。
INDUSTRIAL APPLICABILITY As described in detail above, according to the present invention, it has a fibroblast activating action and an antioxidant action, and prevents or improves aging symptoms such as wrinkles, tarmi, skin firmness and dullness. It was possible to obtain an external preparation for skin that exhibits excellent effects.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 43/00 107 A61P 43/00 107 Fターム(参考) 4C083 AA082 AA111 AA112 AA122 AB032 AB232 AB242 AB312 AB332 AB352 AB432 AC012 AC022 AC072 AC102 AC122 AC242 AC302 AC352 AC422 AC432 AC442 AC482 AC582 AC712 AD042 AD092 AD112 AD152 AD162 AD222 AD282 AD302 AD352 AD492 AD572 BB47 BB51 CC02 CC04 CC05 CC07 CC11 CC12 CC22 CC23 CC25 CC33 DD08 DD17 DD22 DD23 DD27 DD31 DD41 EE12 EE16 4C088 AB12 AC01 AC04 AC05 BA08 BA09 BA10 CA03 NA14 ZA89 ZB21 ZB22 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61P 43/00 107 A61P 43/00 107 F term (reference) 4C083 AA082 AA111 AA112 AA122 AB032 AB232 AB242 AB312 AB332 AB352 AB432 AC012 AC022 AC072 AC102 AC122 AC242 AC302 AC352 AC422 AC432 AC442 AC482 AC582 AC712 AD042 AD092 AD112 AD152 AD162 AD222 AD282 AD302 AD352 AD492 AD572 BB47 BB51 CC02 CC04 CC05 CC07 CC11 CC12 CC22 CC23 CC25 CC33 DD08 DD17 DD22 DD23C27 CC25 CC33 DD08 DD17 DD22 DD23C27 CC12 CC12 AC05 BA08 BA09 BA10 CA03 NA14 ZA89 ZB21 ZB22

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 ミズガンピ属(Pemphis)植物抽
出物を含有することを特徴とする皮膚外用剤。
1. An external preparation for skin, comprising an extract of Pemphis plant.
【請求項2】 老化症状の防止及び改善に効果を有する
請求項1記載の皮膚外用剤。
2. The external preparation for skin according to claim 1, which has an effect of preventing and improving aging symptoms.
【請求項3】 真皮線維芽細胞の賦活作用を有する請求
項1記載の皮膚外用剤。
3. The external preparation for skin according to claim 1, which has a dermal fibroblast activation effect.
【請求項4】 抗酸化作用を有する請求項1記載の皮膚
外用剤。
4. The external preparation for skin according to claim 1, which has an antioxidant effect.
JP2002149521A 2002-05-23 2002-05-23 Topical skin preparation Expired - Fee Related JP4295473B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002149521A JP4295473B2 (en) 2002-05-23 2002-05-23 Topical skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002149521A JP4295473B2 (en) 2002-05-23 2002-05-23 Topical skin preparation

Publications (2)

Publication Number Publication Date
JP2003342149A true JP2003342149A (en) 2003-12-03
JP4295473B2 JP4295473B2 (en) 2009-07-15

Family

ID=29767664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002149521A Expired - Fee Related JP4295473B2 (en) 2002-05-23 2002-05-23 Topical skin preparation

Country Status (1)

Country Link
JP (1) JP4295473B2 (en)

Also Published As

Publication number Publication date
JP4295473B2 (en) 2009-07-15

Similar Documents

Publication Publication Date Title
JP5557414B2 (en) Moisturizer, cell activator, and whitening agent
JP2001114636A (en) Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion
JPH09131393A (en) Deodorant, deodorizing composition, and deodorizing cosmetic
JP3754025B2 (en) Cell activator, antioxidant, and skin external preparation
JP4748962B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP2003267851A (en) Skin care preparation
JP3665049B2 (en) Cell activator, antioxidant, and skin external preparation
JP2004137166A (en) Skin care preparation for external use, cell activator and antioxidant
JP4295473B2 (en) Topical skin preparation
JP4050727B2 (en) Moisturizer, cell activator, whitening agent, antioxidant, and skin external preparation
JP4245862B2 (en) Topical skin preparation
JP3734222B2 (en) External preparation for skin, cell activator, and antioxidant
JP3627862B2 (en) Topical skin preparation
JP4515423B2 (en) Moisturizer, cell activator, and antioxidant
JP4480366B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation
JP4994684B2 (en) Moisturizer, cell activator, and antioxidant
JP4291647B2 (en) Cell activator, whitening agent, collagen production promoter, antioxidant, and skin external preparation
JP2003137766A (en) Collagen production promoter for external use for skin, and hyaluronic acid production promoter for external use for skin
JP4515425B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP3429297B1 (en) External preparation for skin
JP3543306B2 (en) Cell activator and antioxidant
JP4018605B2 (en) Cell activating agent, whitening agent, antioxidant, and skin external preparation
JP4916150B2 (en) Moisturizer, cell activator, antioxidant, and skin external preparation,
JP2003267852A (en) Cell activator
JP5013726B2 (en) Moisturizer, cell activator, antioxidant, and collagenase inhibitor

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040909

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041207

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050228

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090410

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120417

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4295473

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120417

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120417

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130417

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130417

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140417

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees